Skip to main content

Table 4 Antibiotic resistance pattern of S. aureus clinical isolates in terms of clinical samples

From: Contribution of icaADBC genes in biofilm production ability of Staphylococcus aureus clinical isolates collected from hospitalized patients at a burn center in North of Iran

Antibiotics

Resistance pattern

No. (%) of isolates with different susceptibility pattern

P-value

Wound (n = 60)

Blood (n = 17)

Urine (n = 11)

Respiratory (n = 10)

Ascites (n = 2)

Penicillin

NS

60 (100)

15 (88.23)

9 (81.81)

2 (20)

-

0.015

S

-

2 (11.76)

2 (18.18)

8 (80)

2 (100)

 

Cefoxitin

NS

21 (35)

3 (17.64)

2 (18.18)

3 (30)

-

0.387

S

39 (65)

14 (82.35)

9 (81.81)

7 (70)

2 (100)

 

Ceftaroline

NS

11 (18.33)

2 (11.76)

-

1 (10)

-

0.568

S

49 (81.66)

15 (88.23)

11 (100)

9 (90)

2 (100)

 

Ciprofloxacin

NS

40 (66.66)

7 (41.17)

3 (27.27)

3 (30)

-

0.156

S

20 (33.33)

10 (58.82)

8 (72.72)

7 (70)

2 (100)

 

Gentamicin

NS

29 (48.33)

3 (17.64)

-

1 (10)

-

0.178

S

31 (51.66)

14 (82.35)

11 (100)

9 (90)

2 (100)

 

Tetracycline

NS

60 (100)

15 (88.23)

8 (72.72)

7 (70)

-

0.045

S

-

2 (11.76)

3 (27.27)

3 (30)

2 (100)

 

Erythromycin

NS

50 (83.33)

11 (64.70)

-

5 (50)

-

0.038

S

10 (16.66)

6 (35.29)

11 (100)

5 (50)

2 (100)

 

Clindamycin

NS

41 (68.33)

5 (29.41)

-

5 (50)

-

0.058

S

19 (31.66)

12 (70.58)

11 (100)

5 (50)

2 (100)

 
  1. Abbreviations: NS: Non-susceptible that means resistant and intermediate resistant; S: Susceptible